Neurobiology of Aging
Volume 33, Issue 3 , Pages 457-465, March 2012

Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease

  • Becky Inkster

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
    • Department of Clinical Neuroscience, Imperial College, London, United Kingdom
    • Corresponding Author InformationCorresponding author at: Imperial College London, Hammersmith Campus, Room 313, Third Floor, Burlington Danes Building, Du Cane Road, London W12 0NN, United Kingdom. Tel.: +44 (0)20 7594 7993
  • ,
  • Anil W. Rao

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
  • ,
  • Khanum Ridler

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
  • ,
  • Nicola Filippini

      Affiliations

    • Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, Oxford, United Kingdom
    • LENITEM, Laboratory of Epidemiology, Neuroimaging and Telemedicine-IRCCS, S. Giovanni di Dio-FBF, Brescia, Italy
    • Department of Psychiatry, University of Oxford, Oxford, United Kingdom
  • ,
  • Brandon Whitcher

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
  • ,
  • Thomas E. Nichols

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
    • Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, Oxford, United Kingdom
  • ,
  • Sally Wetten

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
  • ,
  • Rachel A. Gibson

      Affiliations

    • GlaxoSmithKline, Harlow, United Kingdom
  • ,
  • Michael Borrie

      Affiliations

    • University of Western Ontario, London, ON, Canada
  • ,
  • Andrew Kertesz

      Affiliations

    • University of Western Ontario, London, ON, Canada
  • ,
  • Danilo A. Guzman

      Affiliations

    • University of Ottawa, Ottawa, ON, Canada
  • ,
  • Inge Loy-English

      Affiliations

    • University of Ottawa, Ottawa, ON, Canada
  • ,
  • Julie Williams

      Affiliations

    • MRC Neuropsychiatric Genetics Group, School of Medicine, Cardiff University, Cardiff, United Kingdom
  • ,
  • Philipp G. Saemann

      Affiliations

    • Max Planck Institute of Psychiatry, Munich, Germany
  • ,
  • Dorothee P. Auer

      Affiliations

    • Max Planck Institute of Psychiatry, Munich, Germany
  • ,
  • Florian Holsboer

      Affiliations

    • Max Planck Institute of Psychiatry, Munich, Germany
  • ,
  • Federica Tozzi

      Affiliations

    • Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy
  • ,
  • Pierandrea Muglia

      Affiliations

    • Genetics Division, Drug Discovery, Medicine Development Centre, GlaxoSmithKline, Research and Development, Verona, Italy
  • ,
  • Emilio Merlo-Pich

      Affiliations

    • Experimental Medical Science, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Verona, Italy
  • ,
  • Paul M. Matthews

      Affiliations

    • GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, United Kingdom
    • Department of Clinical Neuroscience, Imperial College, London, United Kingdom

Received 17 January 2010; received in revised form 8 April 2010; accepted 20 April 2010. published online 07 June 2010.

Abstract 

Replications of the association between APOE-ε4 allele load and regional brain atrophy in Alzheimer's disease (AD) patients hold promise for future studies testing relationships between other disease risk gene variants and brain structure. A polymorphism, rs10868366, in the Golgi phosphoprotein 2 gene, GOLM1, was recently identified as an AD risk factor in a genome-wide association study. In a subset of the same AD cohort, we used voxel-based morphometry to test for association between the disease risk genotype and reduced regional gray matter (GM) volume in AD patients (n = 72). A mean 14% reduction in GM volume was observed in the left frontal gyrus with the higher risk GG genotype. A similar association was observed in an independent, dataset of nondemented subjects (n = 278), although with a smaller effect (1%). This replicated association with GM structural variation suggests that GOLM1 polymorphisms may be related to cognitive phenotypes. The greater effect size in AD patients also suggests that the GG genotype could be a risk factor for the expression of cognitive deficits in AD.

Keywords:  Voxel-based morphometry , Prefrontal cortex , Alzheimer's disease , GOLM1 , Genetic association

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0197-4580(10)00183-1

doi:10.1016/j.neurobiolaging.2010.04.018

Neurobiology of Aging
Volume 33, Issue 3 , Pages 457-465, March 2012